4.5 Article

Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation

Journal

MOLECULAR CANCER RESEARCH
Volume 15, Issue 8, Pages 1073-1084

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-16-0424

Keywords

-

Funding

  1. NIH [5R01-NS-079715-01]
  2. American Cancer Society [RSG-09-273-01-DDC]
  3. Cancer Prevention Research Institute of Texas [CPRIT-RP150301]
  4. The UT MD Anderson Cancer Center-CCE Scholar Program
  5. Cancer Center support grant NCI [CA16672]

Ask authors/readers for more resources

The deubiquitylase (DUB) USP37 is a component of the ubiquitin system and controls cell proliferation by regulating the stability of the cyclin-dependent kinase inhibitor 1B, (CDKN1B/p27Kip1). The expression of USP37 is down-regulated in human medulloblastoma tumor specimens. In the current study, we show that USP37 prevents medulloblastoma growth in mouse orthotopic models, suggesting that it has tumor-suppressive properties in this neural cancer. Here, we also report on the mechanism underlying USP37 loss in medulloblastoma. Previously, we observed that the expression of USP37 is transcriptionally repressed by the RE1 silencing transcription factor (REST), which requires chromatin remodeling factors for its activity. Genetic and pharmacologic approaches were employed to identify a specific role for G9a, a histone methyltransferase (HMT), in promoting methylation of histone H3 lysine-9 (H3K9) mono-and dimethylation, and surprisingly trimethylation, at the USP37 promoter to repress its gene expression. G9a inhibition also blocked the tumorigenic potential of medulloblastoma cells in vivo. Using isogenic lowand high-REST medulloblastoma cells, we further showed a REST-dependent elevation in G9a activity, which further increased mono-and trimethylation of histone H3K9, accompanied by downregulation of USP37 expression. Together, these findings reveal a role for REST-associated G9a and histone H3K9 methylation in the repression of USP37 expression in medulloblastoma. (C) 2017 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available